167
Views
53
CrossRef citations to date
0
Altmetric
Original Research

Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective

, &
Pages 121-131 | Published online: 20 Jan 2015

References

  • YoungAKoduriGExtra-articular manifestations and complications of rheumatoid arthritisBest Pract Res Clin Rheumatol200721590792717870035
  • AletahaDNeogiTSilmanAJ2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeArthritis Rheum20106292569258120872595
  • KvienTKEpidemiology and burden of illness of rheumatoid arthritisPharmacoeconomics2004222 Suppl 111215157000
  • SalaffiFCarottiMGaspariniSIntorciaMGrassiWThe health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy peopleHealth Qual Life Outcomes200972519296831
  • DavidGTandonNWatersHCGunnarssonCKavanaughARheumatoid arthritis and total hip and knee replacement: impact of biologicsAm J Pharm Benefits2014
  • SokkaTAbelsonBPincusTMortality in rheumatoid arthritis: 2008 updateClin Exp Rheumatol2008265 Suppl 51S35S6119026144
  • SinghJAFurstDEBharatA2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care Res (Hoboken)201264562563922473917
  • TakPPKaldenJRAdvances in rheumatology: new targeted therapeuticsArthritis Res Ther201113Suppl 1S521624184
  • BreedveldFCCombeBUnderstanding emerging treatment paradigms in rheumatoid arthritisArthritis Res Ther201113Suppl 1S321624182
  • De GeestSSabatéEAdherence to long-term therapies: evidence for actionEur J Cardiovasc Nurs20032432314667488
  • YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
  • BlomMKievitWFransenJThe reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritisJ Rheumatol200936102171217719723902
  • InghamMReedGBolceRPatterns of anti-TNF treatment in the CORRONA registry: observed responses to maintenance, switching and discontinuation [abstract]Ann Rheum Dis201170Suppl 3415
  • MarkensonJAGibofskyAPalmerWRPersistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registryJ Rheumatol20113871273128121572150
  • CurkendallSPatelVGleesonMCampbellRSZagariMDuboisRCompliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?Arthritis Rheum200859101519152618821651
  • BartonJLImbodenJGrafJGliddenDYelinEHSchillingerDPatient-physician discordance in assessments of global disease severity in rheumatoid arthritisArthritis Care Res (Hoboken)201062685786420535797
  • CurtisJRHobarCHansbroughKInjection-site burning and stinging in patients with rheumatoid arthritis using injectable biologicsCurr Med Res Opin201127717821091097
  • da SilvaJARamiroSPedroSRodriguesAVasconcelosJCBenito-GarciaEPatients- and physicians-priorities for improvement. The case of rheumatic diseasesActa Reumatol Port201035219219920734542
  • Enbrel® (etanercept) [package insert]Thousand Oaks, CAImmunex Corporation2013
  • Humira® (adalimumab) [package insert]North Chicago, ILAbbVie, Inc2014
  • Cimzia® (certolizumab) [package insert]Smyrna, GAUCB, Inc2013
  • Simponi® (golimumab) [package insert]Horsham, PAJanssen Biotech, Inc2014
  • FleischmannRYocumDDoes safety make a difference in selecting the right TNF antagonist?Arthritis Res Ther20046Suppl 2S12S1815228616
  • FraenkelLBogardusSConcatoJFelsonDRisk communication in rheumatoid arthritisJ Rheumatol200330344344812610798
  • van den BemtBJvan LankveldWGHow can we improve adherence to therapy by patients with rheumatoid arthritis?Nat Clin Pract Rheumatol200731268118037928
  • BeckMSearching for Side Effects [webpage on the Internet]New York, NY: The Wall Street Journal2012 Available from: http://online.wsj.com/article/SB10001424052970203920204577193052426275904.html?KEYWORDS=Searching+for+Side+EffectsAccessed February 6, 2013
  • TanakaYHirataSIs it possible to withdraw biologics from therapy in rheumatoid arthritis?Clin Ther201335122028203524290736